메뉴 건너뛰기




Volumn 7, Issue 3 SUPPL., 2011, Pages

Characterizing medical care by disease phase in metastatic colorectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 80052758962     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2011.000304     Document Type: Article
Times cited : (19)

References (19)
  • 1
    • 80052723775 scopus 로고    scopus 로고
    • National Cancer Institute: Cancer Treatment (PDQ). http://www.cancer.gov/ cancertopics/pdq/treatment/colon/healthprofessional/allpages/print
    • Cancer Treatment (PDQ)
  • 2
    • 34248173883 scopus 로고    scopus 로고
    • Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
    • DOI 10.1200/JCO.2006.09.6305
    • Giantonio BJ, Catalano PJ, Meropol NJ, et al: Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539-1544, 2007 (Pubitemid 46733080)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.12 , pp. 1539-1544
    • Giantonio, B.J.1    Catalano, P.J.2    Meropol, N.J.3    O'Dwyer, P.J.4    Mitchell, E.P.5    Alberts, S.R.6    Schwartz, M.A.7    Benson III, A.B.8
  • 4
    • 0027461840 scopus 로고
    • Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
    • Scheithauer W, Rosen H, Kornek GV, et al: Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306:752-775, 1993
    • (1993) BMJ , vol.306 , pp. 752-775
    • Scheithauer, W.1    Rosen, H.2    Kornek, G.V.3
  • 5
    • 0034727063 scopus 로고    scopus 로고
    • Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan study group
    • Saltz LB, Cox JV, Blanke C, et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan study group. N Engl J Med 343:905-914, 2003
    • (2003) N Engl J Med , vol.343 , pp. 905-914
    • Saltz, L.B.1    Cox, J.V.2    Blanke, C.3
  • 9
    • 77955266489 scopus 로고    scopus 로고
    • Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome
    • abstr 3570
    • Van Cutsem E, Lang I, Folprecht G, et al: Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome. J Clin Oncol 28:15s, 2010 (suppl; abstr 3570)
    • (2010) J Clin Oncol , vol.28 , Issue.SUPPL.
    • Van Cutsem, E.1    Lang, I.2    Folprecht, G.3
  • 10
    • 78149250536 scopus 로고    scopus 로고
    • Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study
    • Douillard JY, Siena S, Cassidy J, et al: Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study. J Clin Oncol 28:4697-4705, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 4697-4705
    • Douillard, J.Y.1    Siena, S.2    Cassidy, J.3
  • 12
    • 58849160546 scopus 로고    scopus 로고
    • Lifetime and treatment-phase costs associated with colorectal cancer: Evidence from SEER-Medicare data
    • Lang K, Lines LM, Lee DW, et al: Lifetime and treatment-phase costs associated with colorectal cancer: Evidence from SEER-Medicare data. Clin Gastroenterol Hepatol 7:198-204, 2009
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 198-204
    • Lang, K.1    Lines, L.M.2    Lee, D.W.3
  • 13
    • 79952419581 scopus 로고    scopus 로고
    • Systemic therapy for metastatic colorectal cancer: Patterns of chemotherapy and biologic therapy use in US medical oncology practice
    • Hess GP, Wang PF, Quach D, et al: Systemic therapy for metastatic colorectal cancer: Patterns of chemotherapy and biologic therapy use in US medical oncology practice. J Oncol Pract 6:301-307, 2010
    • (2010) J Oncol Pract , vol.6 , pp. 301-307
    • Hess, G.P.1    Wang, P.F.2    Quach, D.3
  • 14
    • 78650320091 scopus 로고    scopus 로고
    • Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics
    • Song X, Zhao Z, Barber B, et al: Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics. Curr Med Res Opin 27:123-130, 2011
    • (2011) Curr Med Res Opin , vol.27 , pp. 123-130
    • Song, X.1    Zhao, Z.2    Barber, B.3
  • 16
    • 0942279579 scopus 로고    scopus 로고
    • Cost of illness associated with metastatic breast cancer
    • DOI 10.1023/B:BREA.0000010689.55559.06
    • Rao S, Kubisiak J, Gilden D: Cost of illness associated with metastatic breast cancer. Breast Cancer Res Treat 83:25-32, 2004 (Pubitemid 38141890)
    • (2004) Breast Cancer Research and Treatment , vol.83 , Issue.1 , pp. 25-32
    • Rao, S.1    Kubisiak, J.2    Gilden, D.3
  • 17
    • 0026639706 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-Cm administrative databases
    • Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-Cm administrative databases. J Clin Epidemiol 45:613-619, 1992
    • (1992) J Clin Epidemiol , vol.45 , pp. 613-619
    • Deyo, R.A.1    Cherkin, D.C.2    Ciol, M.A.3
  • 19
    • 84964137668 scopus 로고
    • The surgical pathology of rectal cancer: President's address
    • Dukes CE: The surgical pathology of rectal cancer: President's address. Proc R Soc Med 37:131-144, 1944
    • (1944) Proc R Soc Med , vol.37 , pp. 131-144
    • Dukes, C.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.